COAG
Hemab Therapeutics Holdings, Inc.
39.33
+0.56 (+1.44%)
52w low 23.00
55.42 high
50.4% of range
Financial Analysis
| (USD) | Dec 24 | Dec 25 | Trend |
|---|---|---|---|
| Cash & Equivalents | 74.41M | 87.97M | |
| Receivables | 1.58M | 2.63M | |
| Current Assets | 93.23M | 192.55M | |
| Net PP&E | 2.57M | 1.70M | |
| Total Assets | 96.28M | 194.78M | |
| Current Liabilities | 6.68M | 10.68M | |
| Total Debt | 1.73M | 1.22M | |
| Total Liabilities | 211.55M | 371.42M | |
| Retained Earnings | -117.94M | -181.86M | |
| Shareholders Equity | -115.27M | -176.63M | |
| Working Capital | 86.55M | 181.87M | |
| Shares Outstanding | 44.19M | 44.19M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--